Ameriprise’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34M Sell
787,044
-254,891
-24% -$11M 0.01% 1062
2025
Q1
$36M Buy
1,041,935
+608,856
+141% +$21M 0.01% 998
2024
Q4
$11.9M Sell
433,079
-17,302
-4% -$475K ﹤0.01% 1666
2024
Q3
$11.5M Buy
450,381
+415,606
+1,195% +$10.6M ﹤0.01% 1672
2024
Q2
$881K Buy
34,775
+45
+0.1% +$1.14K ﹤0.01% 3200
2024
Q1
$1.07M Sell
34,730
-80
-0.2% -$2.47K ﹤0.01% 3133
2023
Q4
$1.41M Buy
34,810
+300
+0.9% +$12.1K ﹤0.01% 3048
2023
Q3
$910K Sell
34,510
-1,645
-5% -$43.4K ﹤0.01% 3184
2023
Q2
$622K Sell
36,155
-1,465
-4% -$25.2K ﹤0.01% 3356
2023
Q1
$624K Sell
37,620
-23,097
-38% -$383K ﹤0.01% 3338
2022
Q4
$463K Sell
60,717
-530
-0.9% -$4.04K ﹤0.01% 3435
2022
Q3
$609K Buy
61,247
+42,052
+219% +$418K ﹤0.01% 3312
2022
Q2
$174K Buy
+19,195
New +$174K ﹤0.01% 3704
2022
Q1
Sell
-40,372
Closed -$674K 3936
2021
Q4
$674K Sell
40,372
-1,440
-3% -$24K ﹤0.01% 3416
2021
Q3
$1.96M Buy
41,812
+3,293
+9% +$154K ﹤0.01% 2880
2021
Q2
$2.35M Buy
38,519
+3,308
+9% +$202K ﹤0.01% 2857
2021
Q1
$2.17M Sell
35,211
-7,391
-17% -$455K ﹤0.01% 2825
2020
Q4
$3.03M Sell
42,602
-1,637
-4% -$116K ﹤0.01% 2580
2020
Q3
$1.66M Sell
44,239
-2,563
-5% -$96.1K ﹤0.01% 2761
2020
Q2
$1.53M Sell
46,802
-11,690
-20% -$381K ﹤0.01% 2733
2020
Q1
$1.7M Buy
58,492
+29,519
+102% +$856K ﹤0.01% 2564
2019
Q4
$1.02M Buy
28,973
+1,429
+5% +$50.1K ﹤0.01% 3045
2019
Q3
$591K Buy
27,544
+2,429
+10% +$52.1K ﹤0.01% 3240
2019
Q2
$677K Buy
+25,115
New +$677K ﹤0.01% 3211